Sygrid van der Zee Selected Research

fluoroethoxy-benzovesamicol

6/2020	Study protocol of the DUtch PARkinson Cohort (DUPARC): a prospective, observational study of de novo Parkinson's disease patients for the identification and validation of biomarkers for Parkinson's disease subtypes, progression and pathophysiology.
1/2020	Topography of Cholinergic Changes in Dementia With Lewy Bodies and Key Neural Network Hubs.
1/2019	[18 F]Fluoroethoxybenzovesamicol in Parkinson's disease patients: Quantification of a novel cholinergic positron emission tomography tracer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sygrid van der Zee Research Topics

Disease

7	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2019
2	Cognitive Dysfunction 01/2022 - 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	Inflammation (Inflammations) 06/2020
1	Hallucinations (Hallucination) 01/2020
1	Dementia (Dementias) 01/2020

Drug/Important Bio-Agent (IBA)

8	Cholinergic Agents (Cholinergics)IBA 01/2022 - 01/2019
3	fluoroethoxy-benzovesamicolIBA 06/2020 - 01/2019
1	Dopamine (Intropin)FDA LinkGeneric 01/2022
1	Dopamine Agonists (Dopamine Agonist)IBA 01/2022
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	fluorodopa F 18IBA 06/2020
1	Biomarkers (Surrogate Marker)IBA 06/2020
1	Vesicular Acetylcholine Transport Proteins (Vesicular Acetylcholine Transporter)IBA 01/2020

Therapy/Procedure

2	Denervation 01/2021 - 01/2020